Tenon Medical, Inc. Operating Cash Flow
Tenon Medical, Inc. (TNON) reported Operating Cash Flow of -$5.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Tenon Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.76M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.96M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.22M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.82M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$10.74M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$9.88M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$12.18M.
- Tenon Medical, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$12.03M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.72M 10-Q · filed 2026-08-13 | -$7.94M derived: sum of 3 quarters · filed 2026-08-13 | -$11.77M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$2.96M 10-Q · filed 2026-05-15 | -$5.18M derived: sum of 2 quarters · filed 2026-05-15 | -$9.01M derived: sum of 3 quarters · filed 2026-05-15 | -$11.22M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$6.05M derived: sum of 2 quarters · filed 2026-03-27 | -$8.26M derived: sum of 3 quarters · filed 2026-08-13 | -$10.74M 10-K · filed 2026-03-27 |
| 2025-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$6.04M derived: sum of 2 quarters · filed 2026-08-13 | -$8.52M 10-Q · filed 2025-11-13 | -$11.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.70M 10-Q · filed 2026-08-13 | -$7.47M derived: sum of 3 quarters · filed 2026-08-13 | -$9.82M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.48M 10-Q · filed 2026-05-15 | -$5.26M derived: sum of 2 quarters · filed 2026-05-15 | -$7.60M derived: sum of 3 quarters · filed 2026-05-15 | -$10.02M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$5.12M derived: sum of 2 quarters · filed 2026-03-27 | -$7.54M derived: sum of 3 quarters · filed 2026-03-27 | -$9.88M 10-K · filed 2026-03-27 |
| 2024-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.76M derived: sum of 2 quarters · filed 2025-11-13 | -$7.10M 10-Q · filed 2025-11-13 | -$9.38M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$4.76M 10-Q · filed 2025-08-13 | -$7.04M derived: sum of 3 quarters · filed 2025-08-13 | -$10.19M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$2.34M 10-Q · filed 2025-05-13 | -$4.62M derived: sum of 2 quarters · filed 2025-05-13 | -$7.77M derived: sum of 3 quarters · filed 2025-05-13 | -$10.95M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$5.43M derived: sum of 2 quarters · filed 2025-03-26 | -$8.61M derived: sum of 3 quarters · filed 2025-03-26 | -$12.18M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$6.33M derived: sum of 2 quarters · filed 2024-11-14 | -$9.90M 10-Q · filed 2024-11-14 | -$13.29M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$6.75M 10-Q · filed 2024-08-13 | -$10.14M derived: sum of 3 quarters · filed 2024-08-13 | -$13.55M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$3.58M 10-Q · filed 2024-05-15 | -$6.96M derived: sum of 2 quarters · filed 2024-05-15 | -$10.37M derived: sum of 3 quarters · filed 2024-05-15 | -$13.14M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$6.80M derived: sum of 2 quarters · filed 2024-03-29 | -$9.56M derived: sum of 3 quarters · filed 2024-03-29 | -$12.03M 10-K · filed 2024-03-29 |
| 2022-09-30 | -$3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$6.18M derived: sum of 2 quarters · filed 2023-11-14 | -$8.64M 10-Q · filed 2023-11-14 | -$10.33M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$5.23M 10-Q · filed 2023-08-11 | -$6.92M derived: sum of 3 quarters · filed 2023-08-11 | -$8.33M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$2.46M 10-Q · filed 2023-05-09 | -$4.15M derived: sum of 2 quarters · filed 2023-05-09 | -$5.57M derived: sum of 3 quarters · filed 2023-05-09 | -$6.59M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$3.10M derived: sum of 2 quarters · filed 2023-03-10 | -$4.13M derived: sum of 3 quarters · filed 2023-03-10 | -$4.29M 10-K · filed 2023-03-10 |
| 2021-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.44M derived: sum of 2 quarters · filed 2022-11-10 | -$2.60M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$1.19M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$162.00K 10-Q · filed 2022-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |